Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
155b Commerce Drive , Hauppauge, NY, 11788, US
Renejix is the leading end to end CDMO accelerator for small molecule oral dosage forms at a competitive price. We have produced over 200 FDFs, 5+ billion dosages annually, and have a staff of ~500 employees. Take your molecules from concept to commercialization in record time by cutting 20 weeks off early and late phase timelines!
Pegozafermin offers a distinct mechanism of action with potential for enhanced efficacy and tolerability and opportunities for combination development with incretins.
Provides the Morgpeth facility’s Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery.
By: Charlie Sternberg
Brown brings extensive international experience across oncology and radiopharmaceutical development.
By: Rachel Klemovitch
Maria Soler Nunez will take up the newly-created role of Chief Quality Officer.
Aims to develop and market a novel lipid nanoparticle (LNP) platform for nucleic acid delivery.
Released By Douglas CDMO
Caroline brings more than 20 years of experience in the life science industry.
Exploring how innovation, collaboration, and technology are revolutionizing radiopharmaceutical delivery.
By: Tom Brennan
Capitol Biologics will provide process development, early-phase clinical manufacturing, and analytical services to emerging biotechnology companies and U.S. government agencies.
Synthon will be responsible for obtaining final regulatory approval and the manufacture and supply of the product.
This expansion provides an integrated one-stop shop approach for existing and future clients.
The partnership aims to advance ARO-SNCA into clinical trials and explore further applications of Arrowhead’s TRiM platform.
Will combine Quotient Sciences’ Translational Pharmaceutics platform with CPI’s expertise in small scale manufacture of RNA and LNP encapsulation.
David Weinreich is a biopharma leader with extensive experience and a track record in R&D.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
